|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
19805 N. Creek Parkway, Bothell, Washington 98011, US
|
|
Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of COVID-19 and other coronaviruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs.
The company is enrolling subjects in a Phase 1 trial with an antiviral candidate for pandemic and seasonal influenza A, and plans to initiate COVID-19 clinical trials in 2022 with an orally administered and inhalation/pulmonary delivered antiviral candidates.
|
Cocrystal Pharma, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Cocrystal Pharma, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Cocrystal Pharma, Inc. customer service number in your country click here to find.
James J Martin is the CEO of Cocrystal Pharma, Inc.. Or you may call +1.3058610075
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.